Newsroom

Press Releases Events
The Economist - Western firms are becoming interested in a Soviet medicine
Nature Biotechnology - Microbiome-friendly phages join the campaign for better antimicrobials
CF news today - Phage cocktail BX004 safe, seen to reduce P. aeruginosa in small trial
BioSpace - Boehringer Expands BiomX IBD Biomarker Collab, Shutters Crohn's Trial
Independent - Viruses that help: Is bacteriophage therapy the future of medicine?
Cystic Fibrosis News Today - CFF Supporting Phase 1/2 Trial of Phage Therapy for P. aeruginosa Infections
Phase 2 Trial of BX004, Phage Therapy for Bacterial Infections, Advancing
Bacteriophage to the Future: Insights from the 3rd Bacteriophage Therapy Summit
BiomX Reports Third Quarter 2020 Financial Results and Announces Expanded Portfolio of Phage Therapy Candidates
BiomX Presents Preclinical Results of Phage Targeting Klebsiella pneumoniae for Primary Sclerosing Cholangitis and Inflammatory Bowel Disease
Jefferies 2020 Virtual London Healthcare Conference

Sign up for the latest updates

Join our mailing list to receive company updates
delivered to your inbox Join the list

Reach Us

22 Einstein St., Floor 4
Ness Ziona 7414003
Israel

 +972-72-3942377